Veillonella rogosae

Bacteria
General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview

  • Veillonella rogosae is a Gram-negative, non-spore-forming, strictly anaerobic, non-motile, coccus bacterium. It has been detected in at least 2 gut microbiome compilation studies or metastudies. Veillonella rogosae is probably a common, although minor, coloniser of the gut. (Arif2008; Carlier2011Bergey)



  • This organism has been recovered from human faeces, and oral cavity. The risk classification (www.baua.de) for this organism is 1, i.e., low risk of infection and spread. Pathogenicity status unknown, or very unlikely to be pathogenic. Likely to be transient and not a long-term gut commensal.
    • QUIRKS
  • In 43% of Europeans (unseenbio.com). Minor coloniser.
    • GENERAL CHARACTERISTICS (Arif2008); (Carlier2011Bergey);
    Character Response
  • ⥅
  • Substrates assimilated or utilised:
  • lactate;
  • Active enzymes:
  • pyroGlu arylamidase;
  • ±
  • Strain-dependent active enzymes:
  • alkaline phosphatase; arginine dihydrolase; pyrrolidine arylamidase;
    • SPECIAL FEATURES (Arif2008); (Carlier2011Bergey);
    Character Response
  • ✓
  • Metabolites produced:
  • acetate; propionate;
  • ✗
  • Metabolites not produced:
  • indole;
  • ✓
  • Nitrate:
  • reduced
    • RESPONSE TO ANTIBIOTICS (Carlier2011Bergey);
    Class Active Resistant
  • Penicillins:
  • amoxicillin-clavulanic acid;
  • Macrolides:
  • azithromycin;
  • Quinolines:
  • ciprofloxacin; levofloxacin;
  • Heterocycles:
  • metronidazole;
  • Miscellaneous antibiotics:
  • clindamycin;

  • Pfleiderer, A., Lagier, J.-C., Armougom, F., Robert, C., Vialettes, B., & Raoult, D. (2013). Culturomics identified 11 new bacterial species from a single anorexia nervosa stool sample. European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology, 32(11), 1471–1481.

    • Details

    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Firmicutes Class:  Negativicutes Order:  Veillonellales Family:  Veillonellaceae Genus:  Veillonella Gram stain:  neg O2 Relation.:  strictly anaerobic Spore:  No spore Motility:  Sessile Morphology:  Coccus
    Health:  Unknown
    Source:  human faeces, and oral cavity
    		Aesculin:  neg Urea:  neg Arginine:  neg
    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    Mannose:  neg
    SUBSTRATE ASSIMILATION & UTILISATION
    Monosaccharide util/assim Oligosaccharide util/assim Other carboh. util/assim Amino acid util/assim Organic acid util/assim
    Lactate:  +
    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Oxidase:  neg Catalase:  neg Urease:  neg Ac-β-glcamnd:  neg α-Fucosidase:  neg α-Galactosidase:  neg β-Galactosidase:  neg α-Glucosidase:  neg β-Glucosidase:  neg β-Glucuronidase:  neg ArgDH:  d GluDC:  neg AlanineAA:  neg GluGluAA:  neg GlyAA:  neg LeuAA:  neg LeuGlyAA:  neg PyrrolidAA:  d PyrogluAA:  + AlkalineP:  d(w)
    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    		Acetate:  + Propionate:  + Indole:  neg
    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    Augmentin:  S(MIC50): 0.25, MIC90: 2, RNG: (0.06-4)
    penicillin_G:  Var(MIC50): 1, MIC90: 8, RNG: (0.06-8)
    cefalexin:  Var(MIC50): 2, MIC90: 8, RNG: (0.25-16)
    azithromycin:  S(MIC50): 1, MIC90: 2, RNG: (0.125->32)
    erythromycin:  Var(MIC50): 4, MIC90: 8, RNG: (0.5->32)
    ciprofloxacin:  S(MIC50): ≤0.5, MIC90: 4, RNG: (≤0.5->8)
    levofloxacin:  S(MIC50): 0.25, MIC90: 0.5, RNG: (≤0.06-8)
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    tetracycline:  Var(MIC50): 2, MIC90: 16, RNG: (0.5-32)
    metronidazole:  S(MIC50): 2, MIC90: 4, RNG: (0.125-4)
    clindamycin:  S(MIC50): 0.06, MIC90: 0.125, RNG: (≤0.03->32)

    References

    SPECIFIC REFERENCES FOR VEILLONELLA ROGOSAE
  • Arif2008 - Veillonella rogosae sp. nov., an anaerobic, Gram-negative coccus isolated from dental plaque.
  • Carlier2011Bergey - Bergey's manual of systematic bacteriology. Vol. 3, The Firmicutes. Family Veillonellaceae, Genus I. Veillonella
  • ...............................
    • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR VEILLONELLA ROGOSAE
  • Byrd2020 - Stability and dynamics of the human gut microbiome and its association with systemic immune traits.
  • RajilicStojanovic2014 - The first 1000 cultured species of the human gastrointestinal microbiota.
  • ...............................
    • GENERAL REFERENCES FOR VEILLONELLA ROGOSAE
  • Ludwig2009 - Revised road map to the phylum Firmicutes.
    • Added: April 08, 2021